Cefixime: Difference between revisions

Revision as of 19:57, 5 January 2014

Cefixime
Suprax^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

US Brand Names

Suprax^®

FDA Package Insert

References

@@ Line 1: / Line 1: @@
-{{drugbox
+__NOTOC__
-| IUPAC_name = (6''R'',7''R'')-7-{[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxy<br>methoxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-<br>1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
+{{Cefixime}}
-| image = Cefixime.png
+{{CMG}}
-| CAS_number = 79350-37-1
-| ATC_prefix = J01
-| ATC_suffix = DD08
-| ATC_supplemental =
-| PubChem = 54362
-| DrugBank = APRD00583
-| C = 16 | H = 15 | N = 5 | O = 7 | S = 2
-| molecular_weight = 453.452 g/mol
-| bioavailability = 40% to 50%
-| protein_bound = Approximately 60%
-| metabolism =
-| elimination_half-life = Variable<br>Average 3 to 4 hours
-| excretion = [[Kidney|Renal]] and biliary
-| pregnancy_category = B
-| legal_status =
-| routes_of_administration = Oral
-}}
-{{SI}}
+==Overview==
-'''Cefixime''' is an oral third generation [[cephalosporin]] [[antibiotic]].  It was sold under the trade name '''Suprax''' in the USA, until 2003 when it was taken off the market by drug manufacturer [[Wyeth]] after its [[patent]] expired. the oral suspension form of "Suprax" was re-launched by Lupin in the USA.  Cefixime is still available in [[Canada]].  It is used to treat [[gonorrhea]]<ref name="McMillan-2007">{{cite journal | author=McMillan A, Young H. | title=The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime. | journal=Int J STD AIDS | year=2007 | volume=18 | issue=4 | pages=253-4 | id=PMID 17509176}}</ref>, [[tonsilitis]]<ref name="Adam-1995">{{cite journal | author=Adam D, Hostalek U, Tröster K. | title=5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. | journal=Infection | year=1995 | volume=23 | issue=Suppl 2 | pages=S83-6 | id=PMID 8537138}}</ref>, and [[pharyngitis]]<ref name="Adam-1995" />.
+==Category==
+Antibacterial
+==US Brand Names==
+Suprax<sup>®</sup>
-==References==
+==FDA Package Insert==
-<div class="references-small">
-{{reflist|2}}</div>
-==External links==
+'''  [[Cefixime description|Description]]'''
-*[http://www.rxlist.com/cgi/generic/cefixime.htm Suprax Online] - Information about cefixime.
+'''| [[Cefixime clinical pharmacology|Clinical Pharmacology]]'''
-*[http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5146a6.htm Notice to Readers: Discontinuation of Cefixime Tablets --- United States] - A FDA report alerting physicians about the discontinuation of cefixime.
+'''| [[Cefixime microbiology|Microbiology]]'''
+'''| [[Cefixime indications and usage|Indications and Usage]]'''
-{{CephalosporinAntiBiotics}}
+'''| [[Cefixime contraindications|Contraindications]]'''
+'''| [[Cefixime warnings and precautions|Warnings and Precautions]]'''
-[[Category:Cephalosporin antibiotics]]
+'''| [[Cefixime adverse reactions|Adverse Reactions]]'''
-[[Category:Thiazoles]]
+'''| [[Cefixime drug interactions|Drug Interactions]]'''
+'''| [[Cefixime overdosage|Overdosage]]'''
+'''| [[Cefixime clinical studies|Clinical Studies]]'''
+'''| [[Cefixime dosage and administration|Dosage and Administration]]'''
+'''| [[Cefixime how supplied|How Supplied]]'''
+'''| [[Cefixime labels and packages|Labels and Packages]]'''
+==References==
+{{Reflist|2}}
-[[pl:Cefiksym]]
+[[Category:Antibiotics]]
-[[pt:Cefixima]]
+[[Category:Wikinfect]]
-[[th:เซฟิกซิม]]
-{{WikiDoc Help Menu}}
-{{WS}}

Cefixime: Difference between revisions

Revision as of 19:57, 5 January 2014

Overview

Category

US Brand Names

FDA Package Insert

References

Navigation menu